Mylan Laboratories Limited Efavirenz Export Data — India (DGFT 2022–2026)

Name: Mylan Laboratories Limited Efavirenz Export Records India — #2 Exporter, 167 Shipments, $8.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Efavirenz

India Pharmaceutical Trade Intelligence

$60.2M101 Suppliers121 CountriesHS 30049099

ExportsIndia → SOUTH AFRICA49.2%India → BELARUS7.1%

ImportsBELGIUM → India$10.1K UNITED KINGDOM → India$8.5K

Mylan Laboratories Limited — Efavirenz Exporter #2 | $8.3M Trade Value | TransData Nexus | TransData Nexus

Mylan Laboratories Limited — Efavirenz Exporter Profile

Indian Pharmaceutical Exporter · #2 for Efavirenz · $8.3M export value · DGFT Verified

Mylan Laboratories Limited is the #2 Indian exporter of Efavirenz with $8.3M in export value and 167 verified shipments. Mylan Laboratories Limited holds a 13.9% market share in Efavirenz exports across 40 countries. The company exports 91 pharmaceutical products worth $634.8M across 26 therapeutic categories.

Mylan Laboratories Limited — Efavirenz Export Profile: Buyers & Destinations

Mylan Laboratories Limited Efavirenz export treemap — buyers and destination countries | TransData Nexus

Where Does Mylan Laboratories Limited Export Efavirenz?

Country	Value	Shipments	Share
MALAYSIA	$2.3M	61	54.2%
SOUTH AFRICA	$597.9K	12	14.1%
BELARUS	$195.4K	7	4.6%
LIBYAN ARAB REPUBLIC	$173.8K	10	4.1%

Who Are the Top Buyers of Efavirenz from Mylan Laboratories Limited?

Buyer	Country	Value	Orders
PAHANG PHARMACY SDN BHD,	MALAYSIA	$1.2M	35
PAHANG PHARMACY SDN BHD	MALAYSIA	$914.6K	22
VIATRIS HEALTHCARE (PTY) LTD,	SOUTH AFRICA	$400.0K	8
TO THE ORDER OF	LIBYAN ARAB REPUBLIC	$171.8K	8
VIATRIS HEALTHCARE PTY LIMITED	SOUTH AFRICA	$150.0K	3
TISHAS ADDITIONAL LIABILITY COMPANY	BELARUS	$145.4K	3
CENTRAL MEDICAL STORES,	ST KITTS-NEVIS-ANGUILLA	$109.6K	4
UNOPS MYANMAR OC,	MYANMAR	$90.8K	2
PAHANG PHARMACY SDN BHD,,,	MALAYSIA	$88.9K	3
CENTRAL PROCUREMENT	ST LUCIA	$54.3K	3

Mylan Laboratories Limited supplies Efavirenz to 61 buyers globally. The largest buyer is PAHANG PHARMACY SDN BHD, (MALAYSIA), followed by PAHANG PHARMACY SDN BHD (MALAYSIA) and VIATRIS HEALTHCARE (PTY) LTD, (SOUTH AFRICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Efavirenz Formulations Does Mylan Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
EFAVIRENZ 600 MG TABLETS 30S PACKS	$171.6K	4
(EFAMAT) EFAVIRENZ 600 MG TABLETS (30'S)(100,000 PACKS X 30'S = 3000000 NOS)	$150.0K	3
(EFAMAT) EFAVIRENZ 200 MG TABLETS (30'S)(30000 PACKS X 30'S = 900000 NOS)	$131.0K	3
(EFAMAT) EFAVIRENZ 200 MG TABLETS(30'S) (30000 PACKS X 30S = 900000 NOS)	$128.9K	3
EFAVIRENZ 200 MG TABLETS (30S) (PACKS30S BOTTLE) (28776 PACKS X 30S=863280NOS)NOS	$125.4K	3
EFAMAT (EFAVIRENZ 600MG TABLETS) 30S (50000 PACKS X 30S = 1500000 NOS)NOS	$109.9K	3
EFAMAT (EFAVIRENZ 600MG TABLETS) 30S (PACKS 30S BOTTLE) (50000 PACKS X 30S=1500000 NOS)NOS	$109.9K	3
(EFAMAT) EFAVIRENZ 600 MG TABLETS (30'S)(44462 PACKS X 30'S = 1333860 NOS)	$104.4K	3
(EFAMAT) EFAVIRENZ 600 MG TABLETS (30'S)	$100.0K	2
( EFAMAT) EFAVIRENZ 600 MG TABLETS (30'S	$100.0K	2

Mylan Laboratories Limited exports 116 distinct Efavirenz formulations including tablets, capsules, syrups, and combination drugs. The top formulation is EFAVIRENZ 600 MG TABLETS 30S PACKS with 4 shipments worth $171.6K.

How Does Mylan Laboratories Limited Compare to Nearest Efavirenz Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	MYLAN LABORATORIES LIMITED ★	$8.3M	167	40	$50.0K
1	MACLEODS PHARMACEUTICALS LTD	$6.0M	121	33	$50.0K
3	CIPLA LIMITED	$3.0M	59	12	$50.0K

Mylan Laboratories Limited ranks #2 among 101 Indian Efavirenz exporters. Average shipment value of $50.0K compared to the market average of $264.0K. The closest competitors by value are MACLEODS PHARMACEUTICALS LTD and CIPLA LIMITED.

Which Indian Ports Ship Efavirenz Exports?

Port	Shipments	% Share
SAHAR AIR	244	22.5%
SAHAR AIR CARGO ACC (INBOM4)	196	18.1%
Bombay Air	89	8.2%
DELHI AIR CARGO ACC (INDEL4)	73	6.7%
DELHI AIR	64	5.9%
NHAVA SHEVA SEA (INNSA1)	57	5.3%
JNPT/ NHAVA SHEVA SEA	43	4.0%
BANGALORE ACC (INBLR4)	30	2.8%

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Efavirenz Exports

Mylan's export operations are influenced by a complex geopolitical landscape. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structure for Indian pharmaceutical exporters like Mylan. Additionally, diversions around the Cape of Good Hope have further elongated delivery schedules, posing challenges to time-sensitive pharmaceutical shipments.

In the United States, the imposition of tariffs on pharmaceutical imports has prompted Indian companies to reassess their market strategies. While generics have largely remained exempt, the potential for future tariff expansions necessitates vigilance. Mylan, along with other Indian exporters, is exploring market diversification to mitigate reliance on the U.S. market. The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a strategic avenue for expansion. The FTA eliminates tariffs on approximately 97% of EU tariff lines, including pharmaceuticals, thereby enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, providing a counterbalance to uncertainties in the U.S. market.

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Mylan. The FDA's warning letter and import alert in December 2024 concerning the Indore facility underscore the critical importance of stringent quality control measures. The cited violations, including subpar quality control and improper management of manufacturing defects, have necessitated comprehensive corrective actions. Mylan's proactive response aims to restore compliance and reinforce its commitment to quality assurance.

The evolving regulatory environment, particularly in the European Union, further emphasizes the need for adherence to Good Manufacturing Practices (GMP). The EU's Falsified Medicines Directive mandates rigorous compliance to ensure product integrity and patient safety. For Mylan, aligning with these standards is essential to maintain and expand its foothold in the European market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Efavirenz shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Mylan Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 167 individual customs records matching Mylan Laboratories Limited exporting Efavirenz, covering 116 formulations to 43 countries via 61 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 121+ countries, 361+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Efavirenz

Efavirenz

Mylan Laboratories Limited — Efavirenz Exporter Profile

Mylan Laboratories Limited — Efavirenz Export Profile: Buyers & Destinations

Where Does Mylan Laboratories Limited Export Efavirenz?

Who Are the Top Buyers of Efavirenz from Mylan Laboratories Limited?

What Is India's Total Efavirenz Export Value and How Much Does Mylan Laboratories Limited Contribute?

What Is the Average Shipment Value for Mylan Laboratories Limited's Efavirenz Exports?

How Does Mylan Laboratories Limited Compare to Other Indian Efavirenz Exporters?

What Efavirenz Formulations Does Mylan Laboratories Limited Export?

Regulatory Requirements: Exporting Efavirenz to Key Markets

South Africa — SAHPRA

How Does Mylan Laboratories Limited Compare to Nearest Efavirenz Exporters?

Which Indian Ports Ship Efavirenz Exports?

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Efavirenz Exports

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

About Mylan Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Efavirenz Export Data from Mylan Laboratories Limited

Efavirenz Stats

Company Overview

Top Products by Mylan Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source